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Purpose: Application of non-invasive ventilation (NIV) during exercise improves exercise
tolerance in severe COPD patients; however, the underlying mechanism is only partially
unraveled. As part of its known effect to unload the respiratory muscles, we looked for the
inﬂuence of NIV on post-exercise quadriceps muscle endurance.
Patients and methods: We included 25 severe COPD patients entering an outpatient
pulmonary rehabilitation program. They performed, on successive days, three quadriceps
endurance tests at 70% of the maximal strength (1RM) to task failure (TlimQ); 1) control
condition; 2) following constant load cycling exercise to exhaustion without Inspiratory
Pressure Support (TlimQ IPS-); 3) following the same cycling exercise with IPS (TlmQ IPS+).
Results: Dyspnea Borg score was signiﬁcantly reduced at the end of the constant load
cycling exercise with IPS+ compared to IPS- (3.5±2.6 to 4.3±2.3, p<0.05). Compared to
controlled condition, TlimQ was reduced from 78.9±22.7 s to 64.7±22.1 s (p<0.01) with IPS
+ and to 48.9±13.7 s (p<0.001) with IPS-. Sensitive analysis revealed a positive effect of
NIV on TlimQ in only 15 of the 25 included patients (60%) and was unpredictable from
exercise tolerance or maximal quadriceps strength.
Conclusion: Using a simple muscle endurance test, we showed the protective effect of NIVon
the exercise-induced quadriceps dysfunction. This beneﬁcial effect is inconstant in our small
series of patients and could not be predicted by exercise capacity or endurance to exercise.
However, measuring quadriceps muscle endurance following a session of exercise could deter-
mine in which patient NIV would improve the beneﬁt of pulmonary rehabilitation.
Keywords: limb muscle, endurance, non-invasive ventilation, exercise, COPD
Introduction
Exercise tolerance is markedly impaired in severe patients with chronic obstructive
pulmonary diseases (COPD) due to dyspnea and peripheral muscle weakness which
affects up to one-third of patients.1 In most disabled patients, application of non-
invasive ventilation (NIV) was shown to increase exercise endurance and to
enhance the beneﬁt of pulmonary rehabilitation.2 By decreasing the work of breath-
ing, NIV alleviates exercise-induced dyspnea and allows the patients to prolong
exercise. However, this improved exercise tolerance was observed in only 60% of
the patients evaluated by van’t Hul et al.3 It is not clear from the available literature
which patients would beneﬁt the most from NIV and what are the mechanisms
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underlying the improved exercise tolerance. As a potential
consequence of respiratory muscle unloading, Borghi
Silva et al showed an improved leg muscle oxygenation,
measured non-invasively by near-infrared spectroscopy,
when COPD patients exercised with NIV compared to a
sham ventilation.4 This suggests a peripheral muscle effect
of NIV on O2 delivery by reducing the associated hemo-
dynamic consequences of the respiratory work.5
Muscle fatigue is difﬁcult to characterize objectively in
humans. Maximal voluntary contraction of the quadriceps
is largely inﬂuenced by the participation of the subject,
especially after completion of a strenuous exercise. By
using magnetic stimulation of the femoral nerve, several
studies described the development of muscle fatigue after
exercise in healthy subjects as well as in COPD patients.6,7
Not all COPD patients develop quadriceps muscle fatigue
after symptom-limited cycling exercise, underlying the
heterogeneity of the mechanisms limiting exercise perfor-
mance in this population.7,8
In COPD patients, reducing the work of breathing
decreased post-exercise quadriceps fatigue.9 This mechanism
could partly explain the beneﬁcial inﬂuence of NIVon both
acute exercise tolerance and on pulmonary rehabilitation out-
comes, by improving both the central cardiorespiratory and
the peripheral muscle components of exercise limitation.
Measuring endurance of the quadriceps could represent
an alternative to maximal muscle force for assessing mus-
cle function and the development of fatigue following an
exhaustive exercise. Quadriceps endurance is more sys-
tematically affected than maximal force in COPD
patients,10 emphasizing the relevance of evaluating muscle
endurance in this population. During such isolated endur-
ance test (e.g., isolated knee extensions), only a small
muscle mass is active which prevents a ventilatory or
cardiovascular limitation to exercise, and thus makes this
kind of evaluation an attractive way to speciﬁcally test
peripheral muscle function.
Hence, this study aimed to evaluate whether the
reduced work of breathing during cycling exercise with
NIV in moderate-to-severe COPD patients would limit the
importance of muscle fatigue, as assessed by an improved
post-exercise quadriceps endurance. We reasoned that the
reduced diaphragmatic work with NIV would increase
oxygen delivery to peripheral muscle and delayed quad-
riceps fatigue. Moreover, we looked for correlations
between the post-exercise improvements in peripheral
muscle function with NIV and pulmonary function or
exercise capacity parameters.
Materials And Methods
Patients And Study Design
We included patients with moderate-to-severe COPD, accord-
ing to the GOLD criteria,11 referred to our center for a pul-
monary rehabilitation program. All were in a stable condition.
At inclusion in the program, they were evaluated for pulmon-
ary function, exercise capacity and body composition by bio-
impedance analysis (Nutriguard, Pöcking, Germany). The
protocol was approved by our local ethics committee (CPP
Sud Est I 2014-A00145-42). All participants provided written
informed consent, and the study was conducted in accordance
with the Declaration of Helsinki. The ﬂow chart of the study is
given in Figure 1. All the experiments took place in the out-
patient rehabilitation center of the University Hospital of
Saint-Etienne, France.
Maximal power output (Wmax) and peak oxygen con-
sumption (peak VO2) were determined during an incremental
cardiopulmonary exercise test on a computer-electrically
braked cycloergometer. After a 2-min resting period, a
warm-up workload was set at 10 W, followed by 5 to 10 W
increments every minute until exhaustion. Expired gases and
volumes were measured breath by breath on an automated
metabolic card (Ergocard, Medisoft, Sorinnes, Belgium) and
averaged on 20-s periods. Electrocardiogram was recorded
continuously with a 12-lead ECG. Oxygen saturation was
monitored by pulse oximetry and arterialized ear capillary
samples were withdrawn at rest and at peak exercise for
Figure 1 Study ﬂowchart.
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blood gas measurements (ABL 800 Radiometer, Copenhagen,
Denmark). A ventilatory limitation to exercise was deﬁned at
peak exercise as a ventilatory reserve ([VEmax pred –VEmax
measured]/VEmax pred) below 20% and/or as a more than
5 mmHg increase of arterial CO2 pressure. Then, the subjects
were evaluated during three experimental sessions as illu-
strated in Figure 2. The patients performed, in the same
order and separated by at least 48 hrs, three quadriceps endur-
ance tests to exhaustion (TlimQ): 1) without a preceding
cycling exercise (TlimQ control), 2) within 5 mins following
a constant work rate cycling (CWR) test to exhaustion without
inspiratory pressure support (TlimQ IPS-), 3) within 5 mins
following a CWR test with inspiratory pressure support
(TlimQ IPS+), stopped at isotime of the ﬁrst CWR test.
Maximal Voluntary Contraction Of The
Quadriceps (qMVC)
On the dominant thigh, we measured the quadriceps maximal
isometric force on a quadriceps bench with a 90° knee ﬂexion
position. Peak force was determined by a ﬁxed strain gauge
(Globus, Codogné, Italy); 3 reproducible measurements
(±5%) were performed and we recorded the highest value.
Then, we determined one maximal repetition (1RM) as pre-
viously described.12,13
CWR Cycling Test
Patients performed a CWR test on cycloergometer at 75% of
their predetermined Wmax. After 2 mins of unloaded cycling,
the load was increased to 75% Wmax and the patients were
asked to exercise until exhaustion, without encouragements.
Pulse oximetry, transcutaneous carbon dioxide partial pressure
(PtcCO2) and heart rate (Sentec, Basel, Switzerland) were
monitored continuously during the test. Symptoms (dyspnea
and fatigue) were evaluated before starting exercise and at
exhaustion, using a 10 points modiﬁed Borg scale.
Quadriceps Endurance Test
The quadriceps endurance test was performed on a quadriceps
bench with a starting position of 90° knee and hip ﬂexions,
with arms crossed over the chest. The test was adapted from
Serres et al and consisted of extending the dominant leg
against weight corresponding to 70% of 1RM with a pace of
12 movements per minute until exhaustion (duty cycle
40%).14 The test was stoppedwhen the subject could no longer
follow the movement amplitude or frequency on two conse-
cutive movements despite strong verbal encouragements. The
duration was then recorded as the quadriceps endurance limit
time (TlimQ, seconds).
Non-Invasive Ventilation
NIV was applied via a nasal mask in all but one patient (full
face mask). We used spontaneous ventilation with an inspira-
tory assistance mode (AI-VS) (Elisée 150, ResMed Saime,
France). Inspiratory and expiratory pressure levels were
adjusted during a preliminary habituation test as follows. At
rest, we ﬁrst set inspiratory pressure support (IPS) to
10 cmH2O and positive end-expiratory pressure (PEEP) to
4 cmH2O. Then, PEEP was gradually increased up to the
maximum value tolerated by the patient. Thereafter, IPS was
adjusted during cycling exercise in order to maintain dyspnea
score below 5 on the10-points Borg scale. During the cycling
exercise, we also adjusted the ramp and the expiratory trigger
according to the patients’ sensations (comfort to breathe and
inspiratory time). No oxygen was added to the circuit. The set
up of NIV was supervised by the same physiotherapist (PL).
Statistical Analysis
Data are presented as mean ± standard deviation. A positive
response to NIV application was set to >10% increase in
TlimQ between IPS-and IPS+ CWR tests, according to the
reproducibility of similar endurance test reported by
Ribeiro et al.15 No previous data were available to calculate
precisely a sample size. The sample size estimation was
determined according to CONSORT 2010 statement, exten-
sion to randomized pilot and feasibility trials16 and Cohen’s
recommendations who has deﬁned effect-size bounds. So,
with 25 participants, an effect–size around 0.8 (“grossly
perceptible and therefore large”) can be highlighted for a
two-sided type I error at 5%, a statistical power greater than
Figure 2 Design of the study.
Abbreviations: IPS, inspiratory pressure support; TlimQ, quadriceps endurance
limit time; CWR, constant work rate cycling exercise.
Dovepress Labeix et al
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90% and an intra-class correlation coefﬁcient at 0.5 to take
into account between and within participant variability.
TlimQ after each exercise test was compared by ANOVA
after veriﬁcation of the normal distribution of the data by a
Shapiro–Wilk test. Symptoms, heart rate, SpO2 and PtcCO2
were compared using paired Wilcoxon signed-rank test.
Unpaired t-tests with Welsh correction were used for sub-
group analyses. Correlations were performed using least
square regression analysis between exercise capacity and
muscle function and TlimQ changes with IPS. Differences
were considered signiﬁcant at the level of 5%. Statistical
analysis was performed using PRISM V5 software
(Graphpad software, La Jolla, CA, USA).
Results
Study Population
We included 25 COPD patients. Their characteristics,
pulmonary function, exercise capacity and body compo-
sition are given in Tables 1 and 2. Two of them were on
long-term oxygen therapy and one other patient was
treated with nocturnal NIV and supplemental O2.
According to GOLD classiﬁcation, 5 were in stage II,
9 in stage III and 11 patients in stages IV. BODE index
was on average 4.6±1.5 points. Seven patients presented
with muscle wasting (FFMI lower than 17 or 15 kg.m−2,
in males or females, respectively) and six were obese.
The incremental exercise test revealed a reduced exer-
cise tolerance with an obvious ventilatory limitation in
most of the patients (n= 18).
Effect Of NIV During CWR Test
During CWR test, mean pressure support was 13
±2 cmH2O (mean PEEP of 4±1 cmH2O). At isotime with
IPS, dyspnea score decreased signiﬁcantly compared to
IPS- (3.5±2.6 versus 4.3±2.3, p<0.05) but fatigue was
unchanged (3.2±2.3 versus 3.3±2.0, p=0.8). The changes
in SpO2, HR and PtcCO2were not signiﬁcantly different
between both CWR tests (−2.0±4.2 versus −3.4±4.6%,
25.6±15.2 versus 28.4 ±14.8 min−1 and 1.2±7.4 versus
0.2±4.6 mmHg, for IPS+ and IPS- CWR tests, respec-
tively, all non-signiﬁcant).
Post Exercise Quadriceps Function
TlimQ control was on average 78.9±22.7 s, while TlimQ
IPS- was signiﬁcantly reduced to 48.9±13.7 s (p<0.001).
TlimQ IPS+ was decreased compared to control to 64.7
Table 1 Patients’ Characteristics And Pulmonary Function
All Population (n=25) Responders (n=15) Non-Responders (n=10) P-Value Between Groups
Measured (%pred.) Measured (%pred.) Measured (%pred.)
Age (years) 63 ± 9 65 ± 10 61 ± 6 0.32
Sex (M/F) 16/9 10/5 6/4
Height (cm) 166 ± 9 166 ± 10 166 ± 8 0.95
Weight (kg) 73 ± 18 76 ± 16 68 ± 20 0.29
BMI (kg.m−2) 26.6 ± 6.5 27.9 ± 6.6 24.5 ± 6.2 0.21
FFMI (kg.m−2) 18.2 ± 3.8 18.8 ± 3,4 17.2 ± 4.3 0.40
Pulmonary function
FVC (l) 2.55 ± 0.81 (76 ± 18) 2.56 ± 0.68 (78 ± 16) 2.52 ± 1.02 (75 ± 22) 0.59 (0.56)
FEV1 (l) 1.08 ± 0.55 (41 ± 17) 1.09 ± 0.38 (42 ± 14) 1.08 ± 0.76 (39 ± 22) 0.63 (0.32)
FEV1/FVC (%) 43 ± 14 44 ± 15 41 ± 13 0.77
RV (l) 4.51 ± 1.18 (208 ± 63) 4.48 ± 1.25 (202 ± 60) 4.55 ± 1.14 (217 ± 70) 0.92 (0.50)
TLC (l) 7.02 ± 1.47 (124 ± 22) 6.89 ± 1.73 (122 ± 23) 7.23 ± 1.04 (127 ± 21) 0.53 (0.73)
RV/TLC (%) 62 ± 11 62 ± 8 63 ± 14 0.42
MIP (cmH20) 49.8 ± 20.4 (50 ± 19) 56.5 ± 20.2 (54 ± 18) 40.4 ± 17.4 (44 ± 19) 0.05 (0.23)
DLCO (mmol.min−1.kPa−1) 3.51 ± 1.73 (47 ± 21) 3.97 ± 1.94 (53 ± 23), 2.67 ± 0.79 (37 ± 9) 0.13 (0.02)
PaO2 (mmHg) 62.7 ± 8.8 65.0 ± 7.1 59.2 ± 10.3 0.04
PaCO2 (mmHg) 37.5 ± 5.7 36.6 ± 5.5 38.8 ± 6.1 0.23
SaO2 (%) 92.5 ± 4.1 93.5 ± 3.9 91.1 ± 3.9 0.15
Notes: Data are mean ± SD. Numbers between brackets correspond to predicted values, p-values ≤0.05 are noted in bold.
Abbreviations: BMI, body mass index; FFMI, fat-free mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; RV, residual volume; TLC, total lung
capacity; MIP, maximal inspiratory pressure; DLCO, lung diffusing capacity for CO; PaO2, arterial oxygen partial pressure; PaCO2, arterial CO2 partial pressure; SaO2,
arterial oxygen saturation.
Labeix et al Dovepress
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±22.1 s (p<0.01), but to a lesser extent than IPS- (p<0.01).
The larger the decrease in TlimQ after cycling without IPS,
the larger the recovery with IPS (r=0.59, p=0.002). We found
no signiﬁcant correlations between TlimQ control and max-
imal power output, qMVC or CWR duration in ambient air.
The effect of IPS on TlimQ is illustrated in Figure 3.
The signiﬁcant differences between TlimQ under the
different conditions were maintained in subgroups of
patients when we excluded those with less severe disease
(GOLD stage 2, n=5), those with Long-Term Oxygen
Therapy and/or nocturnal NIV (n=3), those with preserved
inspiratory muscle force (MIP>60 cmH20, n=8) or those
with muscle wasting (low FFMI, n=7).
Responders And Non-Responders To NIV
Individuals data demonstrated a beneﬁcial effect of IPS on
TlimQ in 15 patients (60%, responders group, with an aver-
aged change between conditions of 25.4±11.4%), while IPS
did not inﬂuence TlimQ in the 10 others (non-responders
group) with a mean change 1.4±9.1%. Both groups differed
for carbon monoxide diffusing capacity, maximal inspiratory
pressure and resting arterial oxygen partial pressure (PO2)
(all p<0.05). All other pulmonary function and exercise
capacity parameters were similar between groups (see
Tables 1 and 2). Tlim cyclo (p=0.6) and TlimQ (p=0.07)
tended to be shorter in non-responders group compared to
responders group. In responders group only, we found a
positive correlation between TlimQcontrol and the difference
in TlimQ with IPS (r=0.80, p=0.0003).
Discussion
NIV Reduces Quadriceps Muscle
Endurance Impairment
The main result of this study is the reduced quadriceps
muscle endurance impairment following CWR exercise in
COPD patients when inspiratory pressure support is
applied, which occurs in 60% of the patients studied.
IPS during exercise has been previously found beneﬁ-
cial in moderate-to-severe COPD patients by increasing
exercise tolerance. Its main effect is the reduced burden on
respiratory muscle work,17 leveling off minute ventilation
Table 2 Parameters Measured During The Incremental Exercise Test At Peak Exercise And Maximal Quadriceps Force
All Population (n=25) Responders (n=15) Non-Responders (n=10) P-Value Between Groups
Measured (%pred.) Measured (%pred.) Measured (%pred.)
Work rate (W) 46 ± 20 (36 ± 13) 49 ± 20 (36 ± 11) 43 ± 21 (36 ± 17) 0.45 (0.92)
Peak VO2 (mL.min
−1.kg−1) 11.5 ± 3.1 (50 ± 16) 11.0 ± 3.6 (47 ± 14) 12.2 ± 1.9 (53 ± 18) 0.31 (0.38)
VE (l/min) 37.1 ± 15 36.3 ± 11 38.3 ± 20.3 0.78
Breathing Reserve (%) 2 ± 26 6 ± 28 −5 ± 23 0.32
Heart rate (beats/min) 115 ± 18 (70 ± 11) 114 ± 21 (69 ± 12) 118 ± 14 (72 ± 10) 0.49 (0.43)
Δ SaO2 (%) − 5 ± 6 −4 ± 6 −7 ± 6 0.33
Δ PaO2 (mmHg) − 6.6 ± 9.6 −6.2 ± 10.4 −7.2 ± 8.8 0.8
Δ PaCO2 (mmHg) 4.3 ± 4.8 4.1 ± 5.4 4.7 ± 3.9 0.75
Borg score limb fatigue 5.4 ± 2.9 5.5 ± 2.7 5.1 ± 3.4 0.81
Borg score dyspnea 6.6 ± 2.3 6.7 ± 2.4 6.6 ± 2.3 0.95
QMVF (kg) 24.1 ± 9.1(49 ± 12) 24.0 ± 9.0 (48 ± 13) 24.3 ± 9.8 (53 ± 11) 0.93
Notes: Data are mean ± SD. Numbers between brackets correspond to predicted values.
Abbreviations: VO2, oxygen consumption; SaO2, arterial oxygen saturation; PaO2, arterial oxygen partial pressure; PaCO2, arterial CO2 partial pressure; QMVF, maximal
voluntary isometric quadriceps force; Δ, delta from rest to peak exercise.
Figure 3 Effect of a constant work rate cycling exercise without (IPS-) or with (IPS+)
inspiratory pressure support on quadriceps exercise endurance time (TlimQ)
expressed as a percentage of control value. Mean ± SD. Compared to control
condition; **p<0.001, *p<0.01, compared to IPS-: § p<0.01.
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and dynamic hyperinﬂation.18 This noticeably results in
reduced dyspnea sensation. Additional effects have also
been reported which could affect exercise endurance. The
application of IPS could restore normal cardiac output
responses to exercise.19 IPS may also switch part of the
blood ﬂow from respiratory to limb muscles, which could
limit peripheral muscle deoxygenation during exercise.4
Considering the respiratory metaboreﬂex theory,5 we rea-
soned that decreasing respiratory work with IPS could
improve oxygen delivery through exercise-induced sym-
patholysis, and consequently increase muscle endurance.
In the present study, we did not measure cardiac output or
muscle oxygenation which would ascertain the increase in
O2 delivery with IPS and could explain the increase in
TlimQ. However, a previous study demonstrated a reduced
post-exercise quadriceps fatigue with proportional assist
ventilation in COPD patients.9 Muscle fatigue is difﬁcult
to evidence in a clinical setting since it requires supramax-
imal nerve stimulation, which is technically demanding.20
By contrast, measurement of the maximal duration a stan-
dardized task can be sustained, ie, endurance, is easy to
perform for the quadriceps muscle with a resistance train-
ing quadriceps bench. As opposed to maximal force capa-
city, muscle endurance is mainly determined by type I
aerobic ﬁbers and oxygen delivery.21 Thus, it is not sur-
prising that muscle endurance was found substantially
reduced in COPD patients compared to controls.22
Although a reduced endurance time cannot be interpreted
as a proxy of muscle fatigue, its variation after an inter-
vention is directly linked with muscle function and the
patient’s perception of effort. We cannot exclude the inﬂu-
ence of patient’s motivation on the change in quadriceps
endurance following cycling exercise but we believe its
role was limited thanks to strong verbal encouragements in
each condition.
Responders And Non-Responders To NIV
The number of patients increasing TlimQ when IPS was
applied during exercise was similar to those increasing
cycle endurance with IPS 10 cmH2O in the van’t Hul‘s
study.3 Interestingly, this proportion remains similar in
subgroups of patients with more consistent characteristics
(i.e., COPD severity stages 3 and 4 of GOLD, no chronic
respiratory failure, no muscle wasting or preserved max-
imal inspiratory force). The intrinsic variability of the
quadriceps endurance test used in the present study has
not been reported and we deﬁned a cut-off value of 10%
for a positive response to IPS, based on Ribeiro et al's
study on total isokinetic work at 90°/s in COPD patients.15
The 25% variation in endurance time we observed seems
to be large enough to be out of the limits of reproduci-
bility. Exercise capacity (maximal power output or endur-
ance) or quadriceps muscle force could not predict the
response of TlimQ to IPS. However, non-responders
patients had a lower DLCO, arterial PO2 and maximal
inspiratory force compared to responders. This suggests
that IPS could not fully compensate for more altered
pulmonary gas exchanges, and muscle O2 delivery would
not improve to a similar extent than in responders patients.
This interpretation deserves to be conﬁrmed by measuring
muscle oxygenation since such a difference in gas
exchange capacity has never been reported as a predictive
factor of NIV response to exercise tolerance.
The level of ventilator support could explain the extent
of muscle function improvement. We found no difference
in mean inspiratory or expiratory pressures which could
have inﬂuenced breathing mechanics during CWR test
with IPS. Then, the most relevant mechanism underlying
the effect of IPS was an improved oxygen delivery to the
locomotor muscles. Blood oxygenation (SpO2 and
PtcCO2) and heart rate were similar during both CWR
tests which could not explain an improved quadriceps
muscle function. We did not measure blood lactate follow-
ing both CWR exercises to demonstrate potential meta-
bolic changes able to explain the better muscle function
following exercise with IPS.
Novelty Of The Study And Clinical
Implications
In patients entering a pulmonary rehabilitation program,
muscle deconditioning represents a common feature.
Maximal power output during cycling was low in these
patients which may preclude stressing lower limb muscles
to their maximal capacity. The isolated quadriceps endurance
test allowed to assess quadriceps function while ventilation
was not a limiting factor.23 Our results outline an alteration of
muscle endurance capacity following maximal cycling exer-
cise in this population of moderate-to-severe COPD despite
very low mechanical power output. Measuring the variation
of CWR duration with and without IPS gives an overview of
exercise tolerance but cannot differentiate between the bene-
ﬁcial effect of NIV on the respiratory system and on the
peripheral muscle function. We assessed speciﬁcally post-
exercise quadriceps endurance after the same duration of
cycling exercise which allows to evidence the improvement
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in muscle function. We set up a simple test which could help
to personalize exercise training by increasing the intensity of
cycling sessions according to the initial muscle response. For
instance, training intensity would be more rapidly increased
without discomfort in those who improve TlimQ with IPS,
and consequently, training load would be higher compared to
non-responders. One could thus expect higher quadriceps
adaptations to exercise training which would translate into
daily life activities. This remains to be demonstrated in a
prospective controlled study.
To date, no strong predictor of the success of NIV to
improve exercise tolerance and the beneﬁt on pulmonary
rehabilitation has been demonstrated. A reduced maximal
inspiratory pressure would predict a beneﬁcial effect of
NIV during exercise in COPD patients though this has
been recently challenged,24 but the decision to use NIV
during pulmonary rehabilitation remains rather empirical.
The variation in quadriceps endurance following cycling
exercise could evaluate the impact of reducing the work of
breathing by NIV during exercise on muscle function and
therefore could be used to determine the patients who
could beneﬁt from this intervention during pulmonary
rehabilitation. This remains, however, to be demonstrated
in future studies involving COPD in pulmonary rehabilita-
tion program.
Study Limitations
CWR test with IPS was stopped at the same time sustained
without IPS and we cannot demonstrate that IPS improved
exercise tolerance in our patients. Therefore, we can only
speculate that the longer TlimQ would translate in a longer
maximal CWR cycling exercise duration. However, this
effect of IPS on exercise endurance would certainly occur
in our patients based on the signiﬁcant reduction in symp-
toms at the end of CWR IPS+. It was not possible to
randomize the order of the tests since determining ﬁrst
the duration of CWR without IPS was required, similar
to previous studies with similar study design.9 Therefore,
we cannot exclude that part of the effect of IPS on quad-
riceps muscle endurance was due to some potential train-
ing effect, although it is unlikely that repeating twice the
exercise session would lead to a 25% improvement in
muscle endurance as observed in the present study.
Finally, we decided not to use any kind of sham procedure
not able to blind appropriately the patients during the
CWR test. It has been suggested that a level of inspiratory
aid below 10 cmH2O was ineffective to increase exercise
tolerance in COPD patients.3 However, the patients could
not be totally blinded of the application of IPS since the
preliminary habituation test with NIV setting up shows the
patient to what extent the symptoms could be alleviated.
Perspectives
These data bring insight into the complex interplay
between respiratory system and quadriceps function in
COPD patients during exercise. In those patients with a
poor exercise tolerance due to ventilatory limitation and
candidate for NIV application during pulmonary rehabili-
tation, we propose to assess post-exercise quadriceps
endurance with and without a ventilatory support.
Combining the responses to cycling exercise endurance
and to post-exercise quadriceps endurance could allow to
adjust the training load in order to maximize quadriceps
adaptations and would participate in the increased beneﬁt
of pulmonary rehabilitation with NIV.
Conclusion
We demonstrated that the application of NIV during exer-
cise improved quadriceps endurance performed immedi-
ately after a CWR cycling test. This beneﬁcial occurred in
60% of the patients evaluated and was unpredictable from
exercise capacity or endurance to exercise. Therefore,
measuring quadriceps muscle endurance with a relatively
easy to perform protocol as in the present study could
constitute a strategy to assess the beneﬁt of NIV applied
during exercise on peripheral muscle function of the
patients.
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